K
Karen R. Cleary
Researcher at University of Texas MD Anderson Cancer Center
Publications - 158
Citations - 20952
Karen R. Cleary is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Adenocarcinoma & Metastasis. The author has an hindex of 67, co-authored 158 publications receiving 20453 citations. Previous affiliations of Karen R. Cleary include University of Texas Health Science Center at Houston & University of Florida.
Papers
More filters
Journal ArticleDOI
Sarcomatoid carcinoma of the stomach. A report of three cases with immunohistochemical and ultrastructural observations
S. S. Robey-Cafferty,David J. Grignon,Jae Y. Ro,Karen R. Cleary,Alberto G. Ayala,Nelson G. Ordóñez,Bruce Mackay +6 more
TL;DR: Three cases of sarcomatoid carcinoma arising in the stomach are reported, characterized by a mixture of malignant epithelial and spindle cell elements, which had a polypoid configuration; the third was ulcerated and endophytic.
Journal Article
Metastatic Potential of Human Colorectal Carcinomas Implanted into Nude Mice: Prediction of Clinical Outcome in Patients Operated upon for Cure
J. M. Jessup,Raffaella Giavazzi,Debora E. Campbell,Karen R. Cleary,Kiyoshi Morikawa,R. Hostetter,Edward N. Atkinson,Isaiah J. Fidler +7 more
TL;DR: The ability of HCC cells isolated from surgical specimens to grow in athymic nude mice correlates with the development of advanced disease in patients.
Journal ArticleDOI
Plasma cell granuloma of the nasal cavity treated by radiation therapy
Michael J. Seider,Antonio Frias,Lillian M. Fuller,Karen R. Cleary,Pamela Van Tassel,Raymond Alexanian,Stimson P. Schantz +6 more
TL;DR: The tumor was initially resected, but progression was seen at 1‐month follow‐up, and 40‐Gy external beam radiation was given in 20 fractions using a three‐field wedge technique.
Journal ArticleDOI
Anaplastic and sarcomatoid carcinoma of the small intestine: a clinicopathologic study.
TL;DR: It is concluded that anaplastic and sarcomatoid carcinoma is a rare variant of small intestinal carcinoma with an aggressive clinical course.
Journal Article
Monoclonal antibody against human colonic sulfomucin: immunochemical detection of its binding sites in colonic mucosa, colorectal primary carcinoma, and metastases.
TL;DR: The results strongly suggest that this antibody is specific to Colonic sulfomucins or at least to mucins closely related to colonic mucins previously identified by metabolic labeling with [35S]sulfate.